
Real-World Experience Shows TEPEZZA® (teprotumumab-trbw) Was Effective in Treating People With Dysthyroid Optic Neuropathy (DON)
-- Data presented at the North American Neuro-Ophthalmology Society (NANOS) Annual Meeting on March 11-16 in Orlando -- Horizon Therapeutics plc HZNP today announced results of an analysis of real-world treatment with TEPEZZA in Thyroid Eye Disease (TED) …